Artivion Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Artivion Inc 公司

Artivion, Inc. 是一家医疗器械公司，从事制造、加工和分销用于治疗主动脉疾病、心脏瓣膜疾病、主动脉瘤和主动脉夹层患者的心脏和血管外科手术的医疗器械和可植入人体组织。该公司的部门包括医疗器械和保存服务。医疗器械部门包括主动脉支架移植物、手术密封剂和 On-X 的销售。保存服务部门包括保存心脏和血管可植入人体组织的服务。该公司有四个产品系列：主动脉支架移植物、手术密封剂、On-X 机械心脏瓣膜和相关手术产品以及可植入心脏和血管人体组织。主动脉支架移植物包括主动脉弓支架移植物、腹部支架移植物和合成血管移植物。手术密封剂包括 BioGlue 手术粘合剂产品。该公司还销售或分销 PhotoFix 牛手术贴片。

Artivion Inc简介



公司代码AORT

公司名称Artivion Inc

上市日期Feb 12, 1993

CEOMr. James Patrick (Pat) Mackin

员工数量1600

证券类型Ordinary Share

年结日Feb 12

公司地址1655 Roberts Boulevard N W

城市KENNESAW

上市交易所NYSE Consolidated

国家United States of America

邮编30144

电话17704193355

网址https://artivion.com/

公司代码AORT

上市日期Feb 12, 1993

CEOMr. James Patrick (Pat) Mackin

Artivion Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. John E. Davis

Senior Vice President - Global Sales and Marketing

188.49K

--

Mr. Daniel J. Bevevino

Independent Director

150.06K

+4.40%

Mr. Thomas F. Ackerman

Independent Director

149.90K

+4.41%

Ms. Amy D. Horton, CPA

Chief Accounting Officer, Vice President

142.38K

--

Mr. Jon W. Salveson

Independent Director

129.84K

+5.12%

Mr. Lance A. Berry, CPA

Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer

121.36K

+10.09%

Mr. James W. Bullock

Independent Director

68.65K

+10.15%

Mr. Jeffrey H. (Jeff) Burbank

Lead Independent Director

53.80K

+13.32%

Dr. Marshall S. Stanton, M.D.

Senior Vice President, Clinical Research and Chief Medical Officer

48.71K

--

Mr. Matthew A. (Matt) Getz

Vice President - Human Resources

34.12K

-21.64%

名称

名称/职务

职务

持股

持股变动

Mr. John E. Davis

Senior Vice President - Global Sales and Marketing

188.49K

--

Mr. Daniel J. Bevevino

Independent Director

150.06K

+4.40%

Mr. Thomas F. Ackerman

Independent Director

149.90K

+4.41%

Ms. Amy D. Horton, CPA

Chief Accounting Officer, Vice President

142.38K

--

Mr. Jon W. Salveson

Independent Director

129.84K

+5.12%

Mr. Lance A. Berry, CPA

Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer

121.36K

+10.09%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

业务USD

名称

营收

占比

Aortic stent grafts

39.84M

35.27%

On X

25.57M

22.64%

Preservation Services

25.53M

22.60%

Bio Glue

19.29M

17.07%

Surgical sealants

19.29M

17.07%

Other

2.74M

2.43%

暂无数据

业务

地区

业务USD

名称

营收

占比

Aortic stent grafts

39.84M

35.27%

On X

25.57M

22.64%

Preservation Services

25.53M

22.60%

Bio Glue

19.29M

17.07%

Surgical sealants

19.29M

17.07%

Other

2.74M

2.43%

股东统计

更新时间: 8月17日周日

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.75%

Macquarie Investment Management

6.27%

Perceptive Advisors LLC

5.92%

The Vanguard Group, Inc.

5.91%

Fidelity Management & Research Company LLC

4.66%

其他

65.50%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.75%

Macquarie Investment Management

6.27%

Perceptive Advisors LLC

5.92%

The Vanguard Group, Inc.

5.91%

Fidelity Management & Research Company LLC

4.66%

其他

65.50%

股东类型

持股股东

占比

Investment Advisor

50.49%

Investment Advisor/Hedge Fund

28.14%

Private Equity

5.92%

Individual Investor

4.71%

Hedge Fund

2.80%

Research Firm

1.29%

Pension Fund

0.94%

Bank and Trust

0.38%

Venture Capital

0.11%

其他

5.23%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

392

42.59M

90.27%

-124.80K

2025Q2

391

44.35M

103.59%

+1.98M

2025Q1

402

44.36M

103.89%

+1.66M

2024Q4

380

41.09M

97.75%

+880.04K

2024Q3

367

38.98M

93.02%

-790.24K

2024Q2

349

38.52M

92.17%

-784.32K

2024Q1

347

38.26M

91.68%

-2.02M

2023Q4

342

37.08M

90.20%

-1.57M

2023Q3

339

37.01M

90.02%

-1.95M

2023Q2

331

37.22M

87.77%

-1.77M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

5.54M

11.75%

-205.09K

-3.57%

Jun 30, 2025

Macquarie Investment Management

2.96M

6.27%

+52.54K

+1.81%

Jun 30, 2025

Perceptive Advisors LLC

2.79M

5.92%

--

Jun 30, 2025

The Vanguard Group, Inc.

2.79M

5.91%

+16.34K

+0.59%

Jun 30, 2025

Fidelity Management & Research Company LLC

2.20M

4.66%

-584.24K

-21.00%

Jun 30, 2025

Morgan Stanley Smith Barney LLC

1.93M

4.09%

-9.84K

-0.51%

Jun 30, 2025

Juniper Investment Company, LLC

1.86M

3.95%

-229.50K

-10.96%

Aug 08, 2025

Wellington Management Company, LLP

1.71M

3.63%

-13.99K

-0.81%

Jun 30, 2025

State Street Investment Management (US)

1.51M

3.21%

-17.10K

-1.12%

Jun 30, 2025

Fred Alger Management, LLC

1.35M

2.86%

+1.23M

+1018.31%

Jun 30, 2025

持股ETF



更新时间: 11月2日周日

机构名称

占比

AAM Sawgrass US Small Cap Quality Growth ETF

3.92%

Unusual Whales Subversive Democratic Trading ETF

3.39%

ROBO Global Healthcare Technology & Innovation ETF

1.73%

SPDR S&P Health Care Equipment ETF

1.49%

Invesco S&P SmallCap Health Care ETF

1.12%

Invesco Dorsey Wright Healthcare Momentum ETF

0.77%

First Trust Small Cap Growth AlphaDEX Fund

0.68%

Invesco S&P SmallCap 600 Pure Growth ETF

0.61%

Invesco Dorsey Wright SmallCap Momentum ETF

0.39%

iShares Micro-Cap ETF

0.34%

AAM Sawgrass US Small Cap Quality Growth ETF

占比3.92%

Unusual Whales Subversive Democratic Trading ETF

占比3.39%

ROBO Global Healthcare Technology & Innovation ETF

占比1.73%

SPDR S&P Health Care Equipment ETF

占比1.49%

Invesco S&P SmallCap Health Care ETF

占比1.12%

Invesco Dorsey Wright Healthcare Momentum ETF

占比0.77%

First Trust Small Cap Growth AlphaDEX Fund

占比0.68%

Invesco S&P SmallCap 600 Pure Growth ETF

占比0.61%

Invesco Dorsey Wright SmallCap Momentum ETF

占比0.39%

iShares Micro-Cap ETF

占比0.34%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据